Central blood pressure and cardiovascular outcomes in chronic kidney disease

CRIC Study Investigators

doi:10.2215/CJN.08620817

Central blood pressure and cardiovascular outcomes in chronic kidney disease

CRIC Study Investigators

Medicine - Renal and Hypertension Division

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Background and objectives Central BP measurements provide noninvasive measurement of aortic BP; our objectives were to examine the association of central and brachial BP measurements with risk of cardiovascular outcomes and mortality in patients with CKD and to determine the role of central BP measurement in conjunction with brachial BP in estimating cardiovascular risk. Design, setting, participants, &measurements Inaprospective, longitudinal study (the Chronic Renal Insufficiency Cohort), central BP was measured in participants with CKD using the SphygmoCorPVx System. Cox proportional hazards models were used for analyses. Results Mean age of the participants (n=2875) was 60 years old. After a median follow-up of 5.5 years, participants in the highest quartile of brachial systolic BP (≥138 mm Hg) were at higher risk for the composite cardiovascular outcome (hazard ratio, 1.59; 95% confidence interval, 1.17 to 2.17; c statistic, 0.76) but not all-cause mortality (hazard ratio, 1.28; 95% confidence interval, 0.90 to 1.80) compared with those in the lowest quartile. Participants in the highest quartile of central systolic BP were also at higher risk for the composite cardiovascular outcome (hazard ratio, 1.69; 95% confidence interval, 1.24 to 2.31; c statistic, 0.76) compared with participants in the lowest quartile. Conclusions We show that elevated brachial and central BP measurements are both associated with higher risk of cardiovascular disease outcomes in patients with CKD. Measurement of central BP does not improve the ability to predict cardiovascular disease outcomes or mortality in patients with CKD compared with brachial BP measurement.

Original language	English (US)
Pages (from-to)	585-595
Number of pages	11
Journal	Clinical Journal of the American Society of Nephrology
Volume	13
Issue number	4
DOIs	https://doi.org/10.2215/CJN.08620817
State	Published - Apr 6 2018

Bibliographical note

Funding Information:
Funding for the Chronic Renal Insufficiency Cohort (CRIC) Study was obtained under a cooperative agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science award National Institutes of Health (NIH)/ National Center for Advancing Translational Sciences (NCATS) UL1TR000003, Johns Hopkins University grant UL1 TR-000424, University of Maryland General Clinical Research Center grant M01 RR-16500, the Clinical and V 2016.04.26 Translational Science Collaborative of Cleveland, grant UL1TR000439 from the NCATS component of the NIH and the NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research grant UL1TR000433, University of Illinois at Chicago Clinical and Translational Science Award grant UL1RR029879, Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases grant P20 GM109036, and Kaiser Per-manente NIH/National Center for Research Resources University of San Francisco Clinical & Translational Science Institute grant UL1 RR-024131.

Funding Information:
Funding for the Chronic Renal Insufficiency Cohort (CRIC) Study was obtained under a cooperative agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science award National Institutes of Health (NIH)/ National Center for Advancing Translational Sciences (NCATS) UL1TR000003, Johns Hopkins University grant UL1 TR-000424, University of Maryland General Clinical Research Center grant M01 RR-16500, the Clinical and V 2016.04.26 Translational Science Collaborative of Cleveland, grant UL1TR000439 from the NCATS component of the NIH and the NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research grant UL1TR000433, University of Illinois at Chicago Clinical and Translational Science Award grant UL1RR029879, Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases grant P20 GM109036, and Kaiser Permanente NIH/National Center for Research Resources University of San Francisco Clinical & Translational Science Institute grant UL1 RR-024131.

Publisher Copyright:
© 2018 by the American Society of Nephrology.

Keywords

Aorta
Arterial pressure
Blood pressure
Cardiovascular diseases
Chronic
Confidence intervals
Follow-Up studies
Humans
Longitudinal studies
Middle aged
Proportional hazards models
Prospective studies
Renal insufficiency
Risk factors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.2215/CJN.08620817

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969462

OpenUrl availability

Full text

Cite this

@article{c00dc8ee5bcc426f8ed0c86e88b7d243,

title = "Central blood pressure and cardiovascular outcomes in chronic kidney disease",

abstract = "Background and objectives Central BP measurements provide noninvasive measurement of aortic BP; our objectives were to examine the association of central and brachial BP measurements with risk of cardiovascular outcomes and mortality in patients with CKD and to determine the role of central BP measurement in conjunction with brachial BP in estimating cardiovascular risk. Design, setting, participants, &measurements Inaprospective, longitudinal study (the Chronic Renal Insufficiency Cohort), central BP was measured in participants with CKD using the SphygmoCorPVx System. Cox proportional hazards models were used for analyses. Results Mean age of the participants (n=2875) was 60 years old. After a median follow-up of 5.5 years, participants in the highest quartile of brachial systolic BP (≥138 mm Hg) were at higher risk for the composite cardiovascular outcome (hazard ratio, 1.59; 95% confidence interval, 1.17 to 2.17; c statistic, 0.76) but not all-cause mortality (hazard ratio, 1.28; 95% confidence interval, 0.90 to 1.80) compared with those in the lowest quartile. Participants in the highest quartile of central systolic BP were also at higher risk for the composite cardiovascular outcome (hazard ratio, 1.69; 95% confidence interval, 1.24 to 2.31; c statistic, 0.76) compared with participants in the lowest quartile. Conclusions We show that elevated brachial and central BP measurements are both associated with higher risk of cardiovascular disease outcomes in patients with CKD. Measurement of central BP does not improve the ability to predict cardiovascular disease outcomes or mortality in patients with CKD compared with brachial BP measurement.",

keywords = "Aorta, Arterial pressure, Blood pressure, Cardiovascular diseases, Chronic, Confidence intervals, Follow-Up studies, Humans, Longitudinal studies, Middle aged, Proportional hazards models, Prospective studies, Renal insufficiency, Risk factors",

author = "{CRIC Study Investigators} and Mahboob Rahman and Hsu, {Jesse Yenchih} and Niraj Desai and Hsu, {Chi Yuan} and Anderson, {Amanda H.} and Appel, {Lawrence J.} and Jing Chen and Cohen, {Debbie L.} and Drawz, {Paul E.} and Jiang He and Pan Qiang and Ricardo, {Ana C.} and Susan Steigerwalt and Weir, {Matthew R.} and Wright, {Jackson T.} and Xiaoming Zhang and Townsend, {Raymond R.}",

note = "Funding Information: Funding for the Chronic Renal Insufficiency Cohort (CRIC) Study was obtained under a cooperative agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science award National Institutes of Health (NIH)/ National Center for Advancing Translational Sciences (NCATS) UL1TR000003, Johns Hopkins University grant UL1 TR-000424, University of Maryland General Clinical Research Center grant M01 RR-16500, the Clinical and V 2016.04.26 Translational Science Collaborative of Cleveland, grant UL1TR000439 from the NCATS component of the NIH and the NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research grant UL1TR000433, University of Illinois at Chicago Clinical and Translational Science Award grant UL1RR029879, Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases grant P20 GM109036, and Kaiser Per-manente NIH/National Center for Research Resources University of San Francisco Clinical & Translational Science Institute grant UL1 RR-024131. Funding Information: Funding for the Chronic Renal Insufficiency Cohort (CRIC) Study was obtained under a cooperative agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science award National Institutes of Health (NIH)/ National Center for Advancing Translational Sciences (NCATS) UL1TR000003, Johns Hopkins University grant UL1 TR-000424, University of Maryland General Clinical Research Center grant M01 RR-16500, the Clinical and V 2016.04.26 Translational Science Collaborative of Cleveland, grant UL1TR000439 from the NCATS component of the NIH and the NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research grant UL1TR000433, University of Illinois at Chicago Clinical and Translational Science Award grant UL1RR029879, Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases grant P20 GM109036, and Kaiser Permanente NIH/National Center for Research Resources University of San Francisco Clinical & Translational Science Institute grant UL1 RR-024131. Publisher Copyright: {\textcopyright} 2018 by the American Society of Nephrology.",

year = "2018",

month = apr,

day = "6",

doi = "10.2215/CJN.08620817",

language = "English (US)",

volume = "13",

pages = "585--595",

journal = "Clinical Journal of the American Society of Nephrology",

issn = "1555-9041",

publisher = "American Society of Nephrology",

number = "4",

}

TY - JOUR

T1 - Central blood pressure and cardiovascular outcomes in chronic kidney disease

AU - CRIC Study Investigators

AU - Rahman, Mahboob

AU - Hsu, Jesse Yenchih

AU - Desai, Niraj

AU - Hsu, Chi Yuan

AU - Anderson, Amanda H.

AU - Appel, Lawrence J.

AU - Chen, Jing

AU - Cohen, Debbie L.

AU - Drawz, Paul E.

AU - He, Jiang

AU - Qiang, Pan

AU - Ricardo, Ana C.

AU - Steigerwalt, Susan

AU - Weir, Matthew R.

AU - Wright, Jackson T.

AU - Zhang, Xiaoming

AU - Townsend, Raymond R.

N1 - Funding Information: Funding for the Chronic Renal Insufficiency Cohort (CRIC) Study was obtained under a cooperative agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science award National Institutes of Health (NIH)/ National Center for Advancing Translational Sciences (NCATS) UL1TR000003, Johns Hopkins University grant UL1 TR-000424, University of Maryland General Clinical Research Center grant M01 RR-16500, the Clinical and V 2016.04.26 Translational Science Collaborative of Cleveland, grant UL1TR000439 from the NCATS component of the NIH and the NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research grant UL1TR000433, University of Illinois at Chicago Clinical and Translational Science Award grant UL1RR029879, Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases grant P20 GM109036, and Kaiser Per-manente NIH/National Center for Research Resources University of San Francisco Clinical & Translational Science Institute grant UL1 RR-024131. Funding Information: Funding for the Chronic Renal Insufficiency Cohort (CRIC) Study was obtained under a cooperative agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science award National Institutes of Health (NIH)/ National Center for Advancing Translational Sciences (NCATS) UL1TR000003, Johns Hopkins University grant UL1 TR-000424, University of Maryland General Clinical Research Center grant M01 RR-16500, the Clinical and V 2016.04.26 Translational Science Collaborative of Cleveland, grant UL1TR000439 from the NCATS component of the NIH and the NIH Roadmap for Medical Research, Michigan Institute for Clinical and Health Research grant UL1TR000433, University of Illinois at Chicago Clinical and Translational Science Award grant UL1RR029879, Tulane Center of Biomedical Research Excellence for Clinical and Translational Research in Cardiometabolic Diseases grant P20 GM109036, and Kaiser Permanente NIH/National Center for Research Resources University of San Francisco Clinical & Translational Science Institute grant UL1 RR-024131. Publisher Copyright: © 2018 by the American Society of Nephrology.

PY - 2018/4/6

Y1 - 2018/4/6

N2 - Background and objectives Central BP measurements provide noninvasive measurement of aortic BP; our objectives were to examine the association of central and brachial BP measurements with risk of cardiovascular outcomes and mortality in patients with CKD and to determine the role of central BP measurement in conjunction with brachial BP in estimating cardiovascular risk. Design, setting, participants, &measurements Inaprospective, longitudinal study (the Chronic Renal Insufficiency Cohort), central BP was measured in participants with CKD using the SphygmoCorPVx System. Cox proportional hazards models were used for analyses. Results Mean age of the participants (n=2875) was 60 years old. After a median follow-up of 5.5 years, participants in the highest quartile of brachial systolic BP (≥138 mm Hg) were at higher risk for the composite cardiovascular outcome (hazard ratio, 1.59; 95% confidence interval, 1.17 to 2.17; c statistic, 0.76) but not all-cause mortality (hazard ratio, 1.28; 95% confidence interval, 0.90 to 1.80) compared with those in the lowest quartile. Participants in the highest quartile of central systolic BP were also at higher risk for the composite cardiovascular outcome (hazard ratio, 1.69; 95% confidence interval, 1.24 to 2.31; c statistic, 0.76) compared with participants in the lowest quartile. Conclusions We show that elevated brachial and central BP measurements are both associated with higher risk of cardiovascular disease outcomes in patients with CKD. Measurement of central BP does not improve the ability to predict cardiovascular disease outcomes or mortality in patients with CKD compared with brachial BP measurement.

AB - Background and objectives Central BP measurements provide noninvasive measurement of aortic BP; our objectives were to examine the association of central and brachial BP measurements with risk of cardiovascular outcomes and mortality in patients with CKD and to determine the role of central BP measurement in conjunction with brachial BP in estimating cardiovascular risk. Design, setting, participants, &measurements Inaprospective, longitudinal study (the Chronic Renal Insufficiency Cohort), central BP was measured in participants with CKD using the SphygmoCorPVx System. Cox proportional hazards models were used for analyses. Results Mean age of the participants (n=2875) was 60 years old. After a median follow-up of 5.5 years, participants in the highest quartile of brachial systolic BP (≥138 mm Hg) were at higher risk for the composite cardiovascular outcome (hazard ratio, 1.59; 95% confidence interval, 1.17 to 2.17; c statistic, 0.76) but not all-cause mortality (hazard ratio, 1.28; 95% confidence interval, 0.90 to 1.80) compared with those in the lowest quartile. Participants in the highest quartile of central systolic BP were also at higher risk for the composite cardiovascular outcome (hazard ratio, 1.69; 95% confidence interval, 1.24 to 2.31; c statistic, 0.76) compared with participants in the lowest quartile. Conclusions We show that elevated brachial and central BP measurements are both associated with higher risk of cardiovascular disease outcomes in patients with CKD. Measurement of central BP does not improve the ability to predict cardiovascular disease outcomes or mortality in patients with CKD compared with brachial BP measurement.

KW - Aorta

KW - Arterial pressure

KW - Blood pressure

KW - Cardiovascular diseases

KW - Chronic

KW - Confidence intervals

KW - Follow-Up studies

KW - Humans

KW - Longitudinal studies

KW - Middle aged

KW - Proportional hazards models

KW - Prospective studies

KW - Renal insufficiency

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85045150044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045150044&partnerID=8YFLogxK

U2 - 10.2215/CJN.08620817

DO - 10.2215/CJN.08620817

M3 - Article

C2 - 29475992

AN - SCOPUS:85045150044

SN - 1555-9041

VL - 13

SP - 585

EP - 595

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

IS - 4

ER -

Central blood pressure and cardiovascular outcomes in chronic kidney disease

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this